Loading...
Medicare Scrutiny Will Deepen Margin Compression In Managed Care
AnalystLowTarget's Fair Value
US$198.00
69.1% overvalued intrinsic discount10 Sep
US$334.82
1Y
-42.0%7D
-5.3%1Y
-42.0%7D
-5.3%You can edit this narrative until May 18 10:05 PM. Then, changes will post as Updates.